Next Article in Journal
Right Atrial Metastasis of Uterine Leiomyosarcoma Causing Obstructive Shock
Previous Article in Journal
Optimal Prophylactic and Definitive Therapy for Bicalutamide-Induced Gynecomastia: Results of a Meta-analysis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 19
Issue 4
10.3747/co.19.964
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Long-Term Remission after Autologous Stem-Cell Transplantation for Relapsed Histiocytic Sarcoma

by
A. Abu-Sanad
1,
A. Warsi
2,
R.P. Michel
3,
A. Nahal
3,
G. Popradi
2,
J.M. Storring
2,
A.S. Liberman
4 and
T. Alcindor
1,2,*
1
Division of Medical Oncology, McGill University Health Centre, Montreal, QC, Canada
2
Division of Hematology, McGill University Health Centre, Montreal, QC, Canada
3
Department of Pathology, McGill University Health Centre, Montreal, QC, Canada
4
Division of Colorectal Surgery, McGill University Health Centre, Montreal, QC, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2012, 19(4), 289-291; https://doi.org/10.3747/co.19.964
Submission received: 3 May 2012 / Revised: 6 June 2012 / Accepted: 9 July 2012 / Published: 1 August 2012

Abstract

Histiocytic sarcoma is diagnosed according to established criteria. However, treatment is controversial: although lymphoma chemotherapy regimens are often used, their impact on the natural history of the disease is unclear. Here, we report a disease-free survival of 2 years after autologous stem-cell transplantation in a patient with relapsed histiocytic sarcoma.
Keywords: histiocytic sarcoma; chemotherapy; stem-cell transplantation histiocytic sarcoma; chemotherapy; stem-cell transplantation

Share and Cite

MDPI and ACS Style

Abu-Sanad, A.; Warsi, A.; Michel, R.P.; Nahal, A.; Popradi, G.; Storring, J.M.; Liberman, A.S.; Alcindor, T. Long-Term Remission after Autologous Stem-Cell Transplantation for Relapsed Histiocytic Sarcoma. Curr. Oncol. 2012, 19, 289-291. https://doi.org/10.3747/co.19.964

AMA Style

Abu-Sanad A, Warsi A, Michel RP, Nahal A, Popradi G, Storring JM, Liberman AS, Alcindor T. Long-Term Remission after Autologous Stem-Cell Transplantation for Relapsed Histiocytic Sarcoma. Current Oncology. 2012; 19(4):289-291. https://doi.org/10.3747/co.19.964

Chicago/Turabian Style

Abu-Sanad, A., A. Warsi, R.P. Michel, A. Nahal, G. Popradi, J.M. Storring, A.S. Liberman, and T. Alcindor. 2012. "Long-Term Remission after Autologous Stem-Cell Transplantation for Relapsed Histiocytic Sarcoma" Current Oncology 19, no. 4: 289-291. https://doi.org/10.3747/co.19.964

APA Style

Abu-Sanad, A., Warsi, A., Michel, R. P., Nahal, A., Popradi, G., Storring, J. M., Liberman, A. S., & Alcindor, T. (2012). Long-Term Remission after Autologous Stem-Cell Transplantation for Relapsed Histiocytic Sarcoma. Current Oncology, 19(4), 289-291. https://doi.org/10.3747/co.19.964

Article Metrics

Back to TopTop